Skip to main content

Harm Reduction in Europe: Histories, Choices and Hopes

Edited by:
Iga Jeziorska, PhD, Correlation- European Harm Reduction Network, Netherlands

Submission Status: Closed

This collection is no longer accepting submissions.


C-EHRN logo














Harm Reduction Journal
is calling for submissions to our Collection on Harm Reduction in Europe: Histories, Choices and Hopes. We are excited to announce a Call for Papers for a thematic series to be published in the Harm Reduction Journal, in conjunction with the European Harm Reduction Conference taking place in Warsaw in early December 2024, and commemorating the 20th anniversary of the Correlation - European Harm Reduction Network.

Image credit: C-EHRN

  1. Overdose prevention centres (OPCs) are spaces where people can consume previously obtained illicit drugs under the supervision of staff who can intervene to prevent and manage overdose. They have been provided...

    Authors: Jolie R. Keemink, Alex Stevens, Sam Shirley-Beavan, Zarnie Khadjesari and Gillian W. Shorter
    Citation: Harm Reduction Journal 2025 22:36
  2. The COVID-19 pandemic health crisis and its potential implications for people who use drugs (PWUD) created permissive conditions toward social innovation and experimentation. Still, it also exposed gaps in har...

    Authors: Cristiana Vale Pires, Adriana Curado, Ricardo Fuertes, Maria Carmo Carvalho and Helena Valente
    Citation: Harm Reduction Journal 2025 22:29
  3. Protecting individual anonymity is a common practice in harm reduction (HR), as it can mitigate the fears that may prevent people from accessing services. Protecting anonymity usually means applying for servic...

    Authors: Johanna Ranta, Teemu Kaskela, Juha Nurmi, Teemu Ruokolainen and Gillian W. Shorter
    Citation: Harm Reduction Journal 2024 21:224
  4. People who inject drugs (PWID) are at high risk of blood-borne infections, and injection drug use contributes significantly to hepatitis C virus (HCV) transmission. The WHO has therefore set targets of reducin...

    Authors: Gyde Steffen, Amrei Krings, Sarah Guttmann, Nadine Lübke, Kristin Meyer-Schlinkmann, Carsten Tiemann, Jörg Timm, Andreas Walker and Ruth Zimmermann
    Citation: Harm Reduction Journal 2024 21:222
  5. People who use drugs are among the most socially excluded groups in Europe. Qualitative research on Drug Consumption Rooms (DCRs) has reported various benefits to clients, including increased feelings of well-...

    Authors: Benjamin D. Scher, Benjamin W. Chrisinger, David K. Humphreys and Gillian W. Shorter
    Citation: Harm Reduction Journal 2024 21:216
  6. The British model of harm reduction has been referenced as a pioneering approach to substance use in Europe. While many have described the development of UK drug policy through different governments, few studi...

    Authors: Raymond John S. Naguit, Shayla S. Schlossenberg and Praveena K. Fernes
    Citation: Harm Reduction Journal 2024 21:212
  7. Persons who migrate for economic reasons, along with asylum seekers and refugees, face multiple personal experiences and societal inequalities that increase the risk of mental health problems and substance dep...

    Authors: Aline Pouille, Clara De Ruysscher, Lena van Selm, Jan van Amsterdam, Wim van den Brink, Machteld Busz, Roberto Perez Gayo, Marios Atzemis and Wouter Vanderplasschen
    Citation: Harm Reduction Journal 2024 21:208
  8. With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) ...

    Authors: Mojca Maticic, J. Cernosa, C. Loboda, J. Tamse, R. Rigoni, E. Duffell, I. Indave, R. Zimmermann, L. Darragh, J. Moura, A. Leicht, T. Windelinckx, M. Jauffret-Roustide, K. Schiffer and T. Tammi
    Citation: Harm Reduction Journal 2024 21:203
  9. Europe has been at the forefront of harm reduction since its inception. These important early steps were in large part a response to the dramatically expanding HIV epidemic, and investing in these innovative i...

    Authors: Brendan Kahn and Michel Kazatchkine
    Citation: Harm Reduction Journal 2024 21:172

    The Correction to this article has been published in Harm Reduction Journal 2024 21:197

  10. In this article the authors offer their perspective on the changes in the Dutch harm reduction field. From the 1970s to the 1990s, the Netherlands emerged as a leader in harm reduction services, driven by gras...

    Authors: Machteld Busz, Katrin Schiffer, Ancella Voets and Alice Pomfret
    Citation: Harm Reduction Journal 2024 21:163

About the Collection

Harm Reduction Journal is calling for submissions to our Collection on Harm Reduction in Europe: Histories, Choices and Hopes. This special series aims to start a multi-stakeholder and multi-perspective dialogue on the evolution and prospective future of harm reduction in Europe. Our main goal with this thematic issue is to provide a comprehensive and insightful look into the journey of harm reduction across the diverse regions of Europe, examining the changes, challenges, and innovations along the way. We are looking for both primary research articles and thoughtful commentaries that tackle harm reduction from a time-based perspective, digging into its past, understanding its present, and imagining its future.

The launch of this collection was supported by Katrin Schiffer, MPH; Rafaela Rigoni, PhD; and Roberto Perez Gayo, MA, who co-developed the initial framing and conceptualisation. As members of the Advisory Group, they also provided ad-hoc guidance, input, and expertise during the process.

Harm Reduction in Europe: The Past, Present, and Future

Europe has seen a wide variety of harm reduction strategies over the years. From needle exchange programs aimed at reducing the spread of HIV among people who use drugs, to supervised consumption rooms that provide a safer space for substance use, the continent has been at the forefront of innovative harm reduction policies. However, these approaches have not been without controversy and have evolved significantly over time.

As we reflect on the history and practices of harm reduction in Europe, we see a tapestry of different models, policies, and paradigms. The past few decades have witnessed a shift from punitive drug policies, which criminalize drug use, to more compassionate, health-focused approaches. Further, the mainstream harm reduction paradigm has seen an evolution from a health focus, with prioritized professional-led prevention of infectious diseases, towards a more holistic and autonomous view of an individual, and community-led, grassroots initiatives proliferating in recent years. Yet, the journey has been complex and uneven, with different regions adopting harm reduction at different paces and to varying extents.

In the present day, harm reduction in Europe stands at a crucial juncture. While significant progress has been made, challenges remain, including the ongoing stigma faced by people who use drugs, the need for greater and more equitable access to harm reduction services, especially for specific vulnerable groups, and chronic precarity of funding, both in terms of instability and insufficient resources.

Looking ahead, we are interested in exploring innovative and creative visions for the future of harm reduction in Europe. How can we build on the lessons of the past and present to create a more inclusive, effective, and compassionate approach to drug use? How can we ensure that harm reduction services are accessible to all who need them, regardless of where they live or their socioeconomic status?

Seeking Diverse Voices and Perspectives

We are eager to hear from a wide range of contributors – from academics and researchers to service providers and community members, particularly those with living and lived experience of drug use. We believe that a diverse range of perspectives is crucial to creating a comprehensive understanding of harm reduction’s journey in Europe.

Your submissions should critically engage with harm reduction in Europe, examining its evolution over time and offering thoughtful reflections on its future. We are particularly interested in papers that challenge established narratives, offer new insights, and propose innovative solutions.

Submission Guidelines

Back to top

This Collection welcomes submission of primary research articles, commentaries and perspectives. Topics should critically engage with at least two of the temporal aspects: the history, present, and future of harm reduction in Europe. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title "Harm Reduction in Europe: Histories, Choices and Hopes" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.